| | | |  | | | | By Katherine Harmon Courage Molly Ferguson for STAT Sleep advice centered on individual behaviors like reducing screen time ignores structural issues like poverty, stress, and noise pollution. Read More | | By Adam Feuerstein Hyacinth Empinado/STAT This list of the year's worst biopharma CEOs is about holding people and an industry accountable, Adam Feuerstein writes. Read More | | By Sarah Owermohle Felipe Dana/AP Democrats did not deliver on their goal to require every state, including 17 holdouts, to cover postpartum care through Medicaid for a year. Read More | | Sponsored Insight by Dana-Farber Cancer Institute Next-generation drug improves progression-free survival in relapsed chronic lymphocytic leukemia A head-to-head clinical trial in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) has found that zanubrutinib, a next-generation BTK inhibitor, was more effective at preventing disease progression and better tolerated than ibrutinib, the first-generation BTK inhibitor that is the current standard treatment in that setting.
Learn more. | | By Elaine Chen Adobe Certain groups may be experiencing less aggressive treatment, or be skipping doses as insulin prices have surged. Read More | | By Adam Feuerstein Molly Ferguson/STAT Federal prosecutors allege that former CytoDyn CEO Nadir Pourhassan schemed to defraud to investors and enrich himself. Read More | | By Jason Mast Chantal Heijnen for STAT The interest is in Tmunity's leukemia and lymphoma programs, as well as technology that could speed up CAR-T manufacturing. Read More | | By Rhea Boyd and Bruce Lesley and Alexandra Quinn Damian Dovarganes/AP An outbreak of measles in Ohio should sound a warning bell about lax attention to routine vaccinations among children in the U.S. Read More | |
No comments